Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.7746
-0.0014 (-0.18%)
Dec 29, 2025, 3:01 PM EST - Market open
Xtant Medical Holdings Revenue
Xtant Medical Holdings had revenue of $33.26M in the quarter ending September 30, 2025, with 19.04% growth. This brings the company's revenue in the last twelve months to $218.84M, up 92.20% year-over-year. In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth.
Revenue (ttm)
$218.84M
Revenue Growth
+92.20%
P/S Ratio
0.81
Revenue / Employee
$573,634
Employees
232
Market Cap
108.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
| Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
| Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
| Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
| Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
| Dec 31, 2019 | 64.68M | -7.52M | -10.42% |
| Dec 31, 2018 | 72.20M | -10.41M | -12.60% |
| Dec 31, 2017 | 82.61M | -7.39M | -8.21% |
| Dec 31, 2016 | 90.00M | 30.66M | 51.66% |
| Dec 31, 2015 | 59.35M | 24.01M | 67.97% |
| Dec 31, 2014 | 35.33M | 2.26M | 6.83% |
| Dec 31, 2013 | 33.07M | 93.52K | 0.28% |
| Dec 31, 2012 | 32.98M | 2.83M | 9.39% |
| Dec 31, 2011 | 30.15M | 14.73M | 95.55% |
| Dec 31, 2010 | 15.42M | 8.02M | 108.53% |
| Dec 31, 2009 | 7.39M | 6.93M | 1,509.98% |
| Dec 31, 2008 | 459.23K | 262.11K | 132.97% |
| Dec 31, 2007 | 197.12K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
XTNT News
- 18 days ago - Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft - PRNewsWire
- 27 days ago - Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine - PRNewsWire
- 6 weeks ago - Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Xtant Medical Reports Third Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - Xtant Medical Announces Commercial Launch of CollagenX™ - PRNewsWire
- 7 weeks ago - Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025 - PRNewsWire
- 4 months ago - Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 4 months ago - Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript - Seeking Alpha